Preliminary Scientific Programme - Sunday 8 June

8.00 - 8.15
Grand Amphithéâtre
Opening Session

Jean Bousquet, President of the Local
Organising Committee
Paul van Cauwenberge, President of EAACI


8.30-10.15
Room: Bourdeaux
Company Sponsored Symposium 1

Aventis
ANTIHISTAMINES: EVOLUTION OR REVOLUTION?

Chairperson:
Ulrich Wahn, Germany

The allergic march: conquering childhood allergies
Carlos Baena-Cagnani, Argentina

Antihistamines: new challenges...new choices
G Walter Canonica, Italy

Balancing efficacy and safety: the benefits of a wide therapeutic window
Peter Howarth, United Kingdom

Antihistamines: a window of opportunity?
Erwin Gelfand, United States


Room: 342 A
Main Symposium 1

ALLERGY TO COSMETICS AND PERFUMES
(Joint Symposium with European Society of
Contact Dermatitis)

Chairpersons:
Thomas Diepgen, Germany
Annick Barbaud, France

Allergenic ingredients in cosmetics and perfumes
Jean-Pierre Lepoitevin, France

New clinical aspects and allergy testing
An Goossens, Belgium

How sensitising potential is evaluated
David A Basketter, United Kingdom

Will European legislation improve consumer safety?
Torkil Menné, Denmark


Room: Havane
Main Symposium 2

OCCUPATIONAL ASTHMA AND RHINITIS

Chairpersons:
Jean-Luc Malo, Canada
Piero Maestrelli, Italy

Occupational asthma in the UK
Anthony Newman Taylor, United Kingdom

Long term prognosis of occupational asthma
Cristina Mapp, Italy

Links between occupational asthma and rhinitis
Jean-Luc Malo, Canada

Occupational asthma and rhinitis in South Africa
Paul Potter, South Africa


Room: Bleu
Main Symposium 3

JMA FORUM

MOLECULAR CONTROL MECHANISMS IN ALLERGIC DISEASE

Chairpersons:
Iona Agache, Romania
Bart N Lambrecht, The Netherlands

Molecular mechanisms of T cell activation and differentiation by dendritic cells
Hamida Hammad, The Netherlands

Signal transduction in eosinophil development and activation
Paul J. Coffer, The Netherlands

Molecular control of leukocyte migration
Clare M Lloyd, United Kingdom

Molecular control mechanisms in epithelial cell apoptosis
Donna Davies, United Kingdom

Presentation of the Allergopharma Award (10 minutes)


Room: 352 AB
Mini Symposium 1

NEW FRONITERS IN ASTHMA RESEARCH

Chairperson:
Gianni Marone, Italy
Co-chair:
Mark Larché, United Kingdom

Introductory lecturer - New mechanisms and therapeutic aspects of asthma
Gianni Marone, Italy


Room: 252 AB
Oral Abstract Session 1

COMPLIANCE; QOL AND EFFICACY OF IMMUNOTHERAPY

Chairpersons:
Emilio Alvarez Cuesta, Spain
Phil Korenblat, United States


Room: 242 AB
Oral Abstract Session 2

RHINITIS TREATMENT

Chairpersons:
Philippe Gevaert, Belgium
Jean-Michel Klossek, France


Grand Amphithéâtre
EU Session

THE EU AND ALLERGY RESEARCH

Chairpersons:
Paul van Cauwenberge, Belgium
Jean Bousquet, France

EU Research Commission: Overview of EU projects in research
Ana Nieto Nuez, European Commission, Directorate-General for Research

CREATE: Allergen standardisation under the Vth framework programme
Ronald van Ree, The Netherlands

Allergy and asthma Network (T42)
Paul van Cauwenberge, Belgium

The European Community Respiratory Health Survey
Peter Burney, United Kingdom


10.30-12.15
Grand Amphithéâtre
Plenary Session 1

FROM MOLECULAR BIOLOGY OF ALLERGENS TO TREATMENT

Chairpersons:
Paul van Cauwenberge, Belgium
André-Bernard Tonnel, France

From allergen genes to vaccines
Rudolf Valenta, Austria

Allergen standardisation using new technologies
Ronald van Ree, The Netherlands

Recombinant allergens in the diagnosis of allergy
Marianne van Hage-Hamsten, Sweden

Treatment with genetically engineered vaccines
Gabrielle Pauli, France


12.30 - 14.00
Room: 353
EAACI Special Event - Early Diagnosis in Children

EAACI PAEDIATRIC SESSION

Chairpersons:
Philippe Eigenmann, Switzerland
Per Grinsted, Denmark

Early sensitisation and development of allergic diseases
Fabienne Rancé, France

Genetic and environmental factors as determinants for the atopic march
Ulrich Wahn, Germany

Risk factors and predictors for developments and persistence of allergic diseases
Magnus Wickman, Sweden

Allergy testing in children. Indications and methods. (Statement of EAACI Paediatric Section)
Arne Høst, Denmark

Prevention and early treatment of allergic diseases
Antonella Muraro, Italy


14.00 - 15.15
Room: 353
EAACI Special Event - Early Diagnosis in Children

EARLY DIAGNOSIS IN EUROPE

Chairpersons:
Ulrich Wahn, EAACI

Allergy testing in children: why, who, when and how? (Statement of EAACI Paediatric Section)
Arne Høst, President of EAACI Paediatric section

WHO/EU activities in the area of allergy and environment in childhood
Leda Nemer, WHO Europe

Early diagnosis, a patient's right
Erkka Valovirta, EFA

The EAACI Campaign "Early Diagnosis in Children"
Ulrich Wahn, EAACI


12.30-13.30
Meet the Professors Seminars

An opportunity for focussed discussion
with experts in the field. Register for the
seminars on the registration form.

Room: 243
1 Food Allergy
Gisèle Kanny, France + Bodo Niggemann, Germany

Room: 253
2 Advances in Latex Allergy
David A. Levy, France + Timo Reunala, Finland

Room: 343
3 Occupational Asthma
Anthony Newman Taylor, United Kingdom + Santiago Quirce, Spain

Room: 351
4 ß-lactams
Antonino Romano, Italy + Claude Ponvert, France

Room: 241
5 Biological Diagnosis of Drug Allergy
Miguel Blanca, Spain + Hans Merk, Germany

Room: 342 B
6 Cross Reactivities
Francois Lavaud, France + Bernard David, France


12.45-13.30
Grand Amphithéâtre
Pro & Con Session 1

ATOPIC DERMATITIS IS AN ALLERGIC DISEASE

Two experts will present their different
views on a controversial issue. The audience
is encouraged to join the discussion.

Moderators:
Johannes Ring, Germany
Thomas Bieber, Germany

Pro: Thomas A.E Platts-Mills, United States
Con: Carsten Bindslev-Jensen, Denmark


13.30-15.15
Room: Bourdeaux
Company Sponsored Symposium 2

Merck Sharp & Dohme

LTRAs: AN EFFECTIVE TREATMENT APPROACH FOR ADULT AND PAEDIATRIC PATIENTS WITH ‘ONE AIRWAY’ DISEASE

Chairperson:
Jean Bousquet, France

Opening remarks
Jean Bousquet, France

Role of CysLTs as a common systemic mediator of ‘one airway’ disease
Paul van Cauwenberge, Belgium

LTRAs in the treatment of ‘one airway’ disease
Leif Bjermer, Sweden

Expanding role of LTRAs in children
Hans Bisgaard, Denmark

Q&A Session


Room: Bleu
Main Symposium 4

SINUSITIS AND NASAL POLYPOSIS

Chairpersons:
Wytske Fokkens, The Netherlands
Jean-Baptiste Watelet, Belgium

Interleukin 5 receptor regulation and anti-IL5 treatment in nasal polyposis
Philippe Gevaert, Belgium

Staphylococcus aureus enterotoxin as a superantigen
Claus Bachert, Belgium

Does allergic fungal rhinosinusitis exist?
Jean-Michel Klossek, France

Does allergic rhinosinusitis exist?
G Walter Canonica, Italy


Room: Havane
Main Symposium 5

DRUG ALLERGY

Chairpersons:
Pascal Demoly, France
Alain de Weck, Switzerland

Drug metabolism in the skin
Hans F Merk, Germany

Pharmacogenetics of severe drug hypersensitivity reactions
Jean-Claude Roujeau, France

Risk factors in adverse reactions to drugs in HIV
Kevin Park, United Kingdom

Diagnosis of drug-induced skin reactions
Annick Barbaud, France


Room: 352 AB
Main Symposium 6

CHEMOKINES AND THEIR ANTAGONISTS IN ALLERGIC DISEASES

Chairpersons:
Harald Renz, Germany
Pierre Galanaud, France

T cell chemokines
Paola Parrouchi/Sergio Romagnani, Italy

Eosinophil chemokines
A Barry Kay, United Kingdom

Regulation of the chemokine system
Francesco Sinigaglia, Italy

Chemokine receptors: multifaceted therapeutic targets
Zoe Johnson, Switzerland


Room: 241
Poster Discussion Session 1

FOOD ALLERGY

Moderators:
Christof Ebner, Austria
Jean Michel Wal, France


Room: 251
Poster Discussion Session 2

PAEDIATRIC ALLERGIES

Moderators:
Bengt Björkstén, Sweden
Adnan Custovic, United Kingdom


Room: 351
Poster Discussion Session 3

ASTHMA: FROM BENCH TO BESIDE

Moderators:
Alain Didier, France
Marek L. Kowalski, Poland


Room: 342 A
Poster Discussion Session 4

OCCUPATIONAL ALLERGY

Moderators:
Santiago Quirce, Spain
Christine Kopferschmitt-Kubler, France


15.30-17.15
Room: Bourdeaux
Company Sponsored Symposium 3

Schering-Plough Pharmaceuticals

NEW PARADIGMS: AN INTEGRATED APPROACH TO
TREATING AIRWAY AND SKIN DISORDERS

Chairperson:
Jean Bousquet, France

Welcome and introduction
Jean Bousquet, France

Cognition and performance: impact of disease and therapy
Gary Kay, United States

Overview of anti-allergic/anti inflammatory properties of H1-blockers
Glenis Scadding, United Kingdom

Allergic airway disease
Stephen Durham, United Kingdom

Importance of H1-blockers in skin disorders
Ulrich Wahn, Germany

Panel discussion and questions



Room: Bleu
Main Symposium 7

PAEDIATRICS 1: PRIMARY PREVENTION OF ALLERGY

Chairpersons:
Arne Høst, Denmark
Pierre Scheinmann, France

Natural history of asthma in infants
Christophe Delacourt, France

Dietary allergy prevention in infancy (The GINI-Study)
Andrea von Berg, Germany

Aeroallergen avoidance: the experience from the SPACE study
Johannes Forster, Germany

Role of respiratory infections in infants: the lessons from the PIAMA-VIGALL Studies
Herman Neijens, The Netherlands


Room: Havane
Main Symposium 8

EFA SYMPOSIUM

NEW LANGUAGE AND MEDIAS IN ALLERGY AND ASTHMA AND THE PATIENT

Joint Workshop of European Federation of Allergy and Airways Diseases Patients´ Associations (EFA) and EAACI

Chairpersons:
Erkka Valovirta, Finland
Daniel Vervloet, France

Opening
EFA President

Media and quality of information
Esmé Newton-Dunn, United Kingdom

Ethics in allergy
Kristof Nékam, Hungary

Understanding medical language and the patient - Role of the patient associations
Bernd Arents, The Netherlands

Internet and patient-doctor relationship
Nikos Papadopoulos, Greece


Room: 352 AB
Main Symposium 9

CRUCIAL ASPECTS OF IMMUNOTHERAPY

Chairpersons:
Anthony Frew, United Kingdom
Bernard David, France

Efficacy of sublingual immunotherapy: the Cochrane collaboration
Stephen Durham, United Kingdom

ARIA, GINA and GOLD guidelines for the general practitioner
Onno Van Schayck, The Netherlands

The patient selection for immunotherapy
Hans-Jørgen Malling, Denmark

Practical management of subcutaneous immunotherapy
Emilio Alvarez-Cuesta, Spain


Room: 342 A
Oral Abstract Session 3

ADVANCES IN URTICARIA, PENICILLIN ALLERGY AND PATCH TESTING

Chairpersons:
Carsten Bindslev-Jensen, Denmark
Beatrice Crickx, France


Room: 242 AB
Oral Abstract Session 4

MECHANISMS OF ALLERGY

Chairpersons:
Marc Humbert, France
Mübeccel Akdis, Switzerland


Room: 252 AB
Oral Abstract Session 5

ALLERGY DIAGNOSIS

Chairpersons:
Steven Stapel, The Netherlands
Lars Poulsen, Denmark


15.30-17.30
Room: 342 B
JMA Educational Session

Chairpersons:
Katarina Bluemchen, Germany
Ulrike Raap, Germany

How to write a scientific paper
Claus Bachert, Belgium

How to write a grant application
Sergio Bonini, Italy

Marie Curie Grant Programme
Marc Loher - Representative from the European Union, Belgium


17.30-19.00
Room: 352 AB
Satellite Symposium - UCB

ADVANCES IN THE TREATMENT OF PERSISTENT RHINITIS
FROM GUIDELINES TO CLINICAL TREATMENT : XPERT STUDY RESULTS


Chairperson:
Claus Bachert, Belgium

Importance and consequences of ARIA guidelines
Stephen Durham, United Kingdom

XPERT: A global approach to a global problem
Joaquim Mullol-Miret, Spain

Levocetirizine improves quality of life in patients with persistent rhinitis
G Walter Canonica, Italy

Pharmacoeconomics of rhinitis: the role of levocetirizine
Claus Bachert, Belgium


Room: Bourdeaux
Satellite Symposium - Altana

ADVANCES IN MANAGEMENT OF ASTHMA - FOCUS ON ICS THERAPY

Chairperson:
Marc Humbert, France

Redirecting our attention to PK/PD profile: relevance in clinical practice
Hartmut Derendorf, United States

Current ICS therapies: are they as tolerable as you think?
Brian Lipworth, United Kingdom

Ciclesonide: a new approach to ICS therapy in asthma
Jean Bousquet, France


Room: Havane
Satellite Symposium - Hitachi Chemical Diagnostics (HCD)

WHAT IS THE FUTURE OF GENES IN ALLERGY?

Chairperson:
Jean Bousquet, France

Opening remarks
Jean Bousquet, France

A whole genome SNP search fro asthma in the Japanese population
Taro Shirakawa, Japan

Genes in atopic allergy
William Cookson, United Kingdom

Genes in allergy diagnosis
Marek L. Kowalski, Poland

Genes in asthma
Stephen Holgate, United Kingdom

Conclusion
Jean Bousquet, France